Kidney Immune Cell Characterization of Humanized Mouse Models

被引:0
|
作者
Noel, Sanjeev [1 ]
Kurzhagen, Johanna T. [1 ]
Lee, Sul A. [1 ]
Sadasivam, Mohanraj [2 ]
Hamad, Abdel R. A. [2 ]
Pierorazio, Phillip M. [3 ]
Rabb, Hamid [1 ,4 ]
机构
[1] Johns Hopkins Univ, Sch Med, Div Nephrol, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21205 USA
[4] Johns Hopkins Univ, Johns Hopkins Hosp, Sch Med, Div Nephrol, 720 Rutland Ave, Baltimore, MD 21205 USA
来源
KIDNEY360 | 2024年 / 5卷 / 01期
关键词
AKI; cytokines; immunology; ischemia-reperfusion; ischemic renal failure; lymphocytes; T-CELLS; HUMAN CYTOMEGALOVIRUS; MICE; LYMPHOCYTES; ENGRAFTMENT; FEMALE;
D O I
10.34067/KID.0000000000000300
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Successful translation of experimental mouse data to human diseases is limited because of biological differences and imperfect disease models. Humanized mouse models are being used to bring murine models closer to humans. However, data for application in renal immune cellmediated diseases are rare. We therefore studied immune cell composition of three different humanized mouse kidneys and compared them with human kidney. NOG and NOGEXL mice engrafted with human CD34(+) hematopoietic stem cells were compared with NSG mice engrafted with human PBMCs. Engraftment was confirmed with flow cytometry, and immune cell composition in kidney, blood, spleen, and bone marrow was analyzed in different models. The results from immunophenotyping of kidneys from different humanized mouse strains were compared with normal portions of human kidneys. We found significant engraftment of human immune cells in blood and kidney of all tested models. huNSG mice showed highest frequencies of hTCR(+) cells compared with huNOG and huNOGEXL in blood. huNOGEXL was found to have the highest hCD4(+) frequency among all tested models. Non-T cells such as hCD20(+) and hCD11c(+) cells were decreased in huNSG mice compared with huNOG and huNOGEXL. Compared with normal human kidney, huNOG and huNOGEXL mice showed representative immune cell composition, rather than huNSG mice. In summary, humanization results in immune cell infiltration in the kidney with variable immune cell composition of tested humanized mouse models and partially reflects normal human kidneys, suggesting potential use for translational studies.
引用
收藏
页码:96 / 109
页数:14
相关论文
共 50 条
  • [1] Humanized immune-oncology mouse models
    Stecklum, Maria
    Wulf-Goldenberg, Annika
    Brzezicha, Bernadette
    Fichtner, Iduna
    Hoffmann, Jens
    [J]. CANCER RESEARCH, 2017, 77
  • [2] Humanized mouse models for immune-oncology
    Stecklum, M.
    Wulf-Goldenberg, A.
    Paterka, M.
    Brzezicha, B.
    Fichtner, I.
    Hoffmann, J.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 179 - 179
  • [3] Humanized mouse models for preclinical evaluation of novel immune cell therapies, checkpoint inhibitors, and immune cell engagers
    Stecklum, Maria
    Wulf-Goldenberg, Annika
    Brzezicha, Bernadette
    Walther, Wolfgang
    Hoffmann, Jens
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [4] Humanized mouse models for preclinical evaluation of novel immune therapies, checkpoint inhibitors and immune cell engagers
    Stecklum, M.
    Brzezicha, B.
    Rhein, S.
    Walther, W.
    Hoffmann, J.
    [J]. EUROPEAN JOURNAL OF CANCER, 2022, 174 : S12 - S12
  • [5] Preclinical evaluation of novel immune cell therapies, check point inhibitors, and immune cell engagers in humanized mouse models
    Stecklum, Maria
    Wulf-Goldenberg, Annika
    Brzezicha, Bernadette
    Alcaniz, Joshua
    Smits, Glenn
    Walther, Wolfgang
    Hoffmann, Jens
    [J]. MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [6] GENERATION OF HUMANIZED MOUSE MODELS FOR THE PRECLINICAL EVALUATION OF NOVEL IMMUNE CHECKPOINT INHIBITORS, IMMUNE CELL ENGAGERS AND CELL THERAPIES
    Stecklum, Maria
    Wulf-Goldenberg, Annika
    Brzezicha, Bernadette
    Rupp, Christian
    Walther, Wolfgang
    Hoffmann, Jens
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A167 - A167
  • [7] Autologous humanized mouse models of iPSC-derived tumors enable characterization and modulation of cancer-immune cell interactions
    Moquin-Beaudry, Gael
    Benabdallah, Basma
    Maggiorani, Damien
    Le, Oanh
    Li, Yuanyi
    Colas, Chloe
    Raggi, Claudia
    Ellezam, Benjamin
    M'callum, Marie-Agnes
    Dal Soglio, Dorothee
    Guimond, Jean, V
    Paganelli, Massimiliano
    Haddad, Elie
    Beausejour, Christian
    [J]. CELL REPORTS METHODS, 2022, 2 (01):
  • [8] Humanized immune system mouse models: progress, challenges and opportunities
    Allen, Todd M.
    Brehm, Michael A.
    Bridges, Sandra
    Ferguson, Stacy
    Kumar, Priti
    Mirochnitchenko, Oleg
    Palucka, Karolina
    Pelanda, Roberta
    Sanders-Beer, Brigitte
    Shultz, Leonard D.
    Su, Lishan
    PrabhuDas, Mercy
    [J]. NATURE IMMUNOLOGY, 2019, 20 (07) : 770 - 774
  • [9] Humanized mouse models of FcR clearance in immune platelet disorders
    McKenzie, SE
    [J]. BLOOD REVIEWS, 2002, 16 (01) : 3 - 5
  • [10] HUMANIZED MOUSE MODELS FOR PRECLINICAL TESTING OF ANTITUMOUR IMMUNE THERAPY
    Annika, Wulf-Goldenberg
    Maria, Stecklum
    Iduna, Fichtner
    Jens, Hoffmann
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S2 - S2